PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
19-Sep-2024 New drug target discovered for aggressive form of prostate cancer Institute of Cancer Research
19-Sep-2024 Smile Digital Health Completes Drummond Group’s Payer and Patient Access FHIR(R) Recertification 2024 AccessWire
19-Sep-2024 Travel Nurses, Inc. Expands Services With Permanent Placement Jobs AccessWire
19-Sep-2024 DirectTrust Extends TEFCA Support with The Sequoia Project AccessWire
19-Sep-2024 Bioxytran's Medical Breakthrough in Fighting All Viruses AccessWire
19-Sep-2024 Agape ATP Corporation Regains Compliance with Nasdaq’s Minimum Bid Price Rule AccessWire
19-Sep-2024 ful. CashPay: Revolutionizing Healthcare Access for Employers With Uninsured Team Members AccessWire
19-Sep-2024 New Study From Health eCareers Finds Women in Healthcare Satisfied With Their Jobs, but See Obstacles to Progress AccessWire
19-Sep-2024 State of Texas Awards TX-RAMP Level 2 Certification to Sightview's iMedicWare EHR Product Suite AccessWire
19-Sep-2024 Sonoma Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule AccessWire
19-Sep-2024 NeuroEM Therapeutics(R) Accepted into StartUp Health's Alzheimer's Moonshot Community(TM) AccessWire
19-Sep-2024 Biotricity Kicks off Another Pilot Program with a Major Hospital System that Services over 800K Individuals AccessWire
19-Sep-2024 Healthcare Operations Leaders Rank Top Supply Chain Solutions and Identify Critical Gaps in Outdated Materials Management Technology, Black Book(TM) Survey AccessWire
19-Sep-2024 Ensysce Biosciences Submits Phase 3 Protocol to the FDA AccessWire
19-Sep-2024 Surgical Tourniquets Market Research, Driving Forces Analysis Report Pristine Market Insights
19-Sep-2024 Virtual Hospitals Market Set to Revolutionize Global Healthcare Delivery with Advanced Technologies Prophecy Market Insights
19-Sep-2024 Angle PLC Announces Agreement with Recursion Pharmaceuticals AccessWire
19-Sep-2024 Xlife Sciences AG: Successful First Half of 2024 with Strategic Progress and Solid Financial Figures Xlife Sciences AG
19-Sep-2024 AEVIS VICTORIA SA – Publication of Half-Year Report 2024 – Revenue up 8.0% to CHF 527.6 million – Operating profit at EBITDAR level up 21.3% to CHF 87.7 million AEVIS VICTORIA SA
19-Sep-2024 Newron presents H1 2024 results and provides business update Newron Pharmaceuticals S.p.A.